Auxesis Pharma's dermatology portfolio includes cosmeceuticals and dermaceuticals developed for targeted skincare and professional post-treatment care.
The products are designed for precise local application with a focus on skin improvement, recovery and user experience.
Advanced skincare with a scientific foundation.
Cutivelle is being developed as a platform for targeted products addressing skin changes, pigmentation and sensitive skin.
Local treatment where pain and irritation occur.
Lenvée is being developed for rapid and precise application in cases of local skin pain, irritation and redness.
We develop science-based products with the aim of improving quality of life for people and animals — directly where the problem occurs.
All projects are currently under development. Safety, efficacy, formulation and regulatory pathways are evaluated within each respective development programme.